Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
44.56
+0.70 (1.60%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of $2.94 billion as of July 26, 2024. Its market cap has increased by 70.89% in one year.
Market Cap
2.94B
Enterprise Value
2.12B
1-Year Change
70.89%
Ranking
Category
Stock Price
$44.56
Market Cap Chart
Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $2.94B, an increase of 1,883.10%. That is a compound annual growth rate of 15.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 2.89B | 54.22% |
Dec 29, 2023 | 1.87B | -10.70% |
Dec 30, 2022 | 2.10B | 16.42% |
Dec 31, 2021 | 1.80B | 160.11% |
Dec 31, 2020 | 693.20M | 1,825.56% |
Dec 31, 2019 | 36.00M | 5.57% |
Dec 31, 2018 | 34.10M | -91.17% |
Dec 29, 2017 | 386.20M | 7.76% |
Dec 30, 2016 | 358.40M | -76.83% |
Dec 31, 2015 | 1.55B | -5.39% |
Dec 31, 2014 | 1.64B | -16.73% |
Dec 31, 2013 | 1.96B | 372.13% |
Dec 31, 2012 | 415.90M | 262.28% |
Dec 30, 2011 | 114.80M | -13.10% |
Dec 31, 2010 | 132.10M | -10.50% |
Dec 31, 2009 | 147.60M | 17.99% |
Dec 31, 2008 | 125.10M | 237.20% |
Dec 31, 2007 | 37.10M | -62.68% |
Dec 29, 2006 | 99.40M | -28.69% |
Dec 30, 2005 | 139.40M | -6.44% |
Dec 31, 2004 | 149.00M | -15.96% |
Dec 31, 2003 | 177.30M | 19.72% |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
QuidelOrtho | 2.63B |
Vericel | 2.60B |
Myriad Genetics | 2.59B |
PTC Therapeutics | 2.58B |
Intellia Therapeutics | 2.54B |
UFP Technologies | 2.51B |
Geron | 2.51B |
Iovance Biotherapeutics | 2.50B |